Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: the Nutritional AMD Treatment 2 study.

[1]  Johanna M Seddon,et al.  Age-related macular degeneration , 2012, The Lancet.

[2]  C. Schacky.  The Omega-3 Index as a risk factor for cardiovascular diseases. , 2011 .

[3]  R. T. Smith,et al.  A prospective study of reticular macular disease. , 2011, Ophthalmology.

[4]  J. Buring,et al.  Dietary ω-3 fatty acid and fish intake and incident age-related macular degeneration in women. , 2011, Archives of ophthalmology.

[5]  P. Barberger‐Gateau,et al.  Dietary omega-3 fatty acids and the risk for age-related maculopathy: the Alienor Study. , 2011, Investigative ophthalmology & visual science.

[6]  Elvira L. Liclican,et al.  5-Lipoxygenase Metabolite 4-HDHA Is a Mediator of the Antiangiogenic Effect of ω-3 Polyunsaturated Fatty Acids , 2011, Science Translational Medicine.

[7]  Yanhua Lin,et al.  Long-chain and very long-chain polyunsaturated fatty acids in ocular aging and age-related macular degeneration , 2010, Journal of Lipid Research.

[8]  J. Brophy,et al.  Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials , 2010, BMC cardiovascular disorders.

[9]  T. Kaptchuk,et al.  Biological, clinical, and ethical advances of placebo effects , 2010, The Lancet.

[10]  E. Agrón,et al.  {omega}-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study. , 2009, The American journal of clinical nutrition.

[11]  N. Bazan.  Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection. , 2009, Prostaglandins, leukotrienes, and essential fatty acids.

[12]  P. Marik,et al.  Omega‐3 Dietary Supplements and the Risk of Cardiovascular Events: A Systematic Review , 2009, Clinical cardiology.

[13]  D. English,et al.  Fat consumption and its association with age-related macular degeneration. , 2009, Archives of ophthalmology.

[14]  E. Souied,et al.  Nutritional AMD Treatment Phase I (NAT-1): Feasibility of Oral DHA Supplementation in Age-Related Macular Degeneration , 2009, European journal of ophthalmology.

[15]  R. Klein,et al.  The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. , 2008, Archives of ophthalmology.

[16]  R. de Caterina,et al.  Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease. , 2008, Prostaglandins, leukotrienes, and essential fatty acids.

[17]  P. D. de Jong,et al.  Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. , 2008, The American journal of clinical nutrition.

[18]  T. Wong,et al.  Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. , 2008, Archives of ophthalmology.

[19]  A. Simopoulos,et al.  The Importance of the Omega-6/Omega-3 Fatty Acid Ratio in Cardiovascular Disease and Other Chronic Diseases , 2008, Experimental biology and medicine.

[20]  Lois E. H. Smith,et al.  Increased dietary intake of ω-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis , 2007, Nature Medicine.

[21]  F. Cangemi.  TOZAL Study: An open case control study of an oral antioxidant and omega-3 supplement for dry AMD , 2007, BMC ophthalmology.

[22]  C. Delcourt,et al.  Dietary fat and the risk of age-related maculopathy: the POLANUT Study , 2007, European Journal of Clinical Nutrition.

[23]  J. Lau,et al.  Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. , 2006, Atherosclerosis.

[24]  E. Souied,et al.  SPA-1 : sémiologie du phénotype de la dégénérescence maculaire liée à l’âge : précurseurs , 2006 .

[25]  B. Rosner,et al.  Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. , 2006, Archives of ophthalmology.

[26]  P. Mitchell,et al.  Dietary fatty acids and the 5-year incidence of age-related maculopathy. , 2006, Archives of ophthalmology.

[27]  M. Mattson,et al.  The plasma membrane redox system in aging , 2006, Ageing Research Reviews.

[28]  J. Féher,et al.  Improvement of Visual Functions and Fundus Alterations in Early Age-Related Macular Degeneration Treated with a Combination of Acetyl-L-Carnitine, n-3 Fatty Acids, and Coenzyme Q10 , 2005, Ophthalmologica.

[29]  R. T. Smith,et al.  Automated detection of macular drusen using geometric background leveling and threshold selection. , 2005, Archives of ophthalmology.

[30]  J. Sangiovanni,et al.  The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina , 2005, Progress in Retinal and Eye Research.

[31]  S. Resnikoff,et al.  Global data on visual impairment in the year 2002. , 2004, Bulletin of the World Health Organization.

[32]  Chris A. Johnson,et al.  Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses. , 2004, Archives of ophthalmology.

[33]  F. Ferris.  PROGRESSION OF AGE-RELATED MACULAR DEGENERATION ASSOCIATION WITH DIETARY FAT, TRANSUNSATURATED FAT, NUTS, AND FISH INTAKE , 2004 .

[34]  R. Spencer,et al.  A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa. , 2004, American journal of ophthalmology.

[35]  W. Willett,et al.  Dietary fat and risk for advanced age-related macular degeneration. , 2001, Archives of ophthalmology.

[36]  Simon P. Harding,et al.  Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2. , 2001, American journal of ophthalmology.

[37]  E. Rimm,et al.  Prospective study of dietary fat and the risk of age-related macular degeneration. , 2001, The American journal of clinical nutrition.

[38]  N. Bressler,et al.  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. , 1999, Archives of ophthalmology.

[39]  E. Chew.  DIETARY FAT AND FISH INTAKE AND AGE-RELATED MACULOPATHY , 2000 .

[40]  F. Carrat,et al.  Comparison of a new method for the direct and simultaneous assessment of LDL- and HDL-cholesterol with ultracentrifugation and established methods. , 2000, Clinical chemistry.

[41]  A. Munnich,et al.  The γ e4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration , 1998 .

[42]  M. C. Leske,et al.  The Lens Opacities Classification System III , 1993 .

[43]  A. Simopoulos.  Omega-3 fatty acids in health and disease and in growth and development. , 1991, The American journal of clinical nutrition.

[44]  L T Chylack,et al.  Lens opacities classification system II (LOCS II) , 1989, Archives of ophthalmology.

[45]  C. von Schacky.  The Omega-3 Index as a risk factor for cardiovascular diseases. , 2011, Prostaglandins & other lipid mediators.

[46]  Usha Chakravarthy,et al.  The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. , 2008, Ophthalmology.

[47]  T. Wong,et al.  Dietary -3 Fatty Acid and Fish Intake in the Primary Prevention of Age-Related Macular Degeneration , 2008 .

[48]  E. Souied,et al.  [SPA-1: semiology for phenotyping AMD: precursors]. , 2006, Journal francais d'ophtalmologie.

[49]  A. Zajac.  Substances Affirmed as Generally Recognized as Safe: Menhaden Oil , 2005 .

[50]  Neil M Bressler,et al.  Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. , 2002, American journal of ophthalmology.

[51]  C. Astre,et al.  Validation of a food-frequency questionnaire using multiple-day records and biochemical markers: application of the triads method. , 2000, Journal of epidemiology and biostatistics.

[52]  A. Munnich,et al.  The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. , 1998, American journal of ophthalmology.